Novo Nordisk preps Saxenda sales drive in Latin America after its 'phenomenal' Q1
admin 22nd May 2017 Uncategorised 0Novo Nordisk, facing more pressure than ever in the U.S., is revving up its Latin American plans for the obesity drug Saxenda, which shows particular promise in Mexico.
More: Novo Nordisk preps Saxenda sales drive in Latin America after its 'phenomenal' Q1
Source: fierce